Medicine Information

Bextra and Vioxx Withdrawal Spawn Advertising Pause from Bristol Myers


Pharmaceutical giant Bristol Myers Squibb has announced that they will suspend direct-to-consumer advertising for their prescription drug products for a year. This comes in the wake of the well-publicized withdrawals of Merck's Vioxx and Pfizer's Bextra, two non-steroidal anti-inflammatory drugs (NSAIDs) that were voluntarily withdrawn from the market recently. Studies showed that they increase the likelihood of strokes and heart attacks among patients that take them for prolonged periods of time. This represents an unusual move for a pharmaceutical company, as they tend to spend a large portion of their annual advertising budget on direct-to-consumer advertising.

It is possible that Bristol Myers recognizes that consumers are becoming concerned about new drugs being approved by the FDA and advertised heavily, only to find out later that the drugs have previously unknown and possibly dangerous side effects. Consumers have learned that advertising a drug as "new and improved" doesn't necessarily mean that it is new, or improved, or even safe. In short, customers are suspicious of pharmaceutical advertising, and the drug companies are to be commended for taking notice of that fact.

Since 1997, drug companies have been allowed by U.S. law to advertise directly to consumers. This has led to an astonishing number of ads on television and radio, as consumers see ads showing one happy person after another. The ads suggest that the happiness shown is a result of the use of the product, and a voiceover quickly mumbles through the known, and sometimes lengthy, list of side effects. Patients are encouraged to speak with their doctor, and they have been doing so in record numbers. The problem, as Bristol Myers know realizes, is that consumers are well aware that the withdrawn Bextra and Vioxx were advertised as being safe. This has naturally led to a general suspicion of all advertised drugs, and Bristol Myers correctly sees that they could be the victims of a drug-company backlash, even if they didn't manufacture any of the withdrawn products.

This will probably save Bristol Myers a lot of money in the short term, as their advertising would have largely gone to waste. The Food and Drug Administration is taking steps to make sure that the drugs that reach the U.S. market are safe, and in time, the public will again become more trusting of pharmaceutical advertising. In the meantime, TV viewers will be spared from having to watch the sometimes-cryptic drug ads, which often prompt questions of "What does this drug do?"

©Copyright 2005 by Retro Marketing.

Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


MORE RESOURCES:

National Academy of Sports Medicine Launches New Course ...
MarketWatch - 9 hours ago
CALABASAS, CA, Nov 21, 2008 (MARKET WIRE via COMTEX) -- The National Academy of Sports Medicine (NASM; www.nasm.org), a leader in fitness training ...


PR Web (press release)

BodyLogicMD Sponsors American Academy of Anti-Aging Medicine
MarketWatch - 17 hours ago
"It is a natural step for BodyLogicMD in terms of demonstrating our growth and support in the field of anti-aging medicine and bioidentical hormone therapy. ...
BodyLogicMD Opens Bioidentical Hormone Therapy Location in Chicago PR Web (press release)
all 12 news articles


University of South Alabama College of Medicine Chooses MDaudit(TM)
MarketWatch - 3 hours ago
... WIRE) -- Hayes Management Consulting announced today that it will provide its MDaudit(TM) software to University of South Alabama College of Medicine. ...


Fresh News

Three Employees Fired After Patient Chokes on Medicine, Dies
FOXNews - Nov 20, 2008
GOLDSBORO, NC — North Carolina officials have fired three employees and disciplined others in the death of a patient who was neglected for more than 22 ...
Firings a good first step in neglect case CharlotteObserver.com
all 38 news articles


BBC News

The uneasy link between war and medicine
BBC News, UK - 13 hours ago
Each portray the stark realities of war in their time, and show how medicine has struggled over the years to heal the injured. In one corner of the Wellcome ...
War and Medicine at the Wellcome Collection, NW1 Times Online
all 2 news articles


China Daily

The wrong medicine
TheDay, CT - 11 hours ago
If we had any reasonable expectation that a $25 billion federal loan would fix what ails the Detroit auto industry, we would support it. ...
Video: Automakers Testify As Hopes for Aid Falter AssociatedPress
Detroit bailout? No way! The Oregonian - OregonLive.com
Auto bailout must come with strings Visalia Times-Delta
all 1,752 news articles


Entry Level Finding Ways to Help Children With Cancer
New York Times, United States - 5 hours ago
She comes to the job with a master’s degree in Oriental medicine from Touro College and a lifelong love of cooking. On doing acupuncture on small children: ...


Overworked doctors would not recommend careers in medicine
SmartBrief, DC - 2 hours ago
A survey of primary care doctors indicates most feel overworked and would not recommend medicine as a career. Nearly half the doctors who responded to the ...


Research and Markets: This Global Research Report in Medicine and ...
MarketWatch - Nov 19, 2008
Nanomaterials, nanophotonics, nanoelectronics and nanoscience in medicine & biology represent the largest concentration of R&D. ...


Four of Molecular Medicine’s Thought Leaders will Keynote at ...
PR Web (press release), WA - 7 hours ago
Cambridge Healthtech Institute’s (CHI) flagship event, the Molecular Medicine Tri-Conference (February 24-27, 2009) will feature four of molecular ...

Medicine - Google News

home | site map
© 2006